Skip to main content Advertisement Menu Search Search Publisher main menu Journals Submissions Publishing services About My Account Follow BioMed Central Twitter Facebook Journal of Hematology & Oncology Journal of Hematology & Oncology main menu Home About Articles Articles Recent Most accessed Recent articles Recent articles RSS 1. Research Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis Fei Teng, Wen-Yan Tian, Ying-Mei Wang, Yan-Fang Zhang, Fei Guo, Jing Zhao, Chao Gao and Feng-Xia Xue Published on: 6 February 2016 2. Research Haplo-insufficiency of both BubR1 and SGO1 accelerates cellular senescence Sung-Hyun Park, Steve Xie, Chinthalapally V. Rao and Wei Dai Published on: 4 February 2016 3. Research Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer Zibing Wang, Yuqing Liu, Rui’e Li, Yiman Shang, Yong Zhang, Lingdi Zhao, Wei Li, Yonghao Yang, Xiaojie Zhang, Tiejun Yang, Changfu Nie, Feng Han, Ying Liu, Suxia Luo, Quanli Gao and Yongping Song Published on: 3 February 2016 4. Research GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways Laura Guerenne, Stéphanie Beurlet, Mohamed Said, Petra Gorombei, Carole Le Pogam, Fabien Guidez, Pierre de la Grange, Nader Omidvar, Valérie Vanneaux, Ken Mills, Ghulam J Mufti, Laure Sarda-Mantel, Maria Elena Noguera, Marika Pla, Pierre Fenaux, Rose Ann Padua… Published on: 27 January 2016 5. Research An engineered multicomponent bone marrow niche for the recapitulation of hematopoiesis at ectopic transplantation sites Mónica S. Ventura Ferreira, Christian Bergmann, Isabelle Bodensiek, Kristina Peukert, Jessica Abert, Rafael Kramann, Paul Kachel, Björn Rath, Stephan Rütten, Ruth Knuchel, Benjamin L. Ebert, Horst Fischer, Tim H. Brümmendorf and Rebekka K. Schneider Published on: 25 January 2016 View all articles Most accessed articles Most accessed articles RSS 1. Review Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options Gerhard J Molderings, Stefan Brettner, Jürgen Homann and Lawrence B Afrin Published on: 22 March 2011 2. Review Ibrutinib and novel BTK inhibitors in clinical development Akintunde Akinleye, Yamei Chen, Nikhil Mukhi, Yongping Song and Delong Liu Published on: 19 August 2013 3. Review The effects of β-glucan on human immune and cancer cells Godfrey Chi-Fung Chan, Wing Keung Chan and Daniel Man-Yuen Sze Published on: 10 June 2009 4. Review Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers Xinyuan Li, Pu Fang, Jietang Mai, Eric T Choi, Hong Wang and Xiao-feng Yang Published on: 25 February 2013 5. Research Article TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion Bin Li, Ming-Zhu Huang, Xiao-Qiang Wang, Bang-Bao Tao, Jun Zhong, Xu-Hui Wang, Wen-Chuan Zhang and Shi-Ting Li Published on: 22 July 2015 View all articles Aims and scope Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Editor's quote "Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists." Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology Experimental Hematology & Oncology Submit your research to our companion journal, Experimental Hematology & Oncology Research highlights Journal of Hematology & Oncology is now publishing Research Highlights, commentaries on recently published work that place the new research in the context of the current literature. Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer Janice Lu AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell- mediated immunotherapy Jingjing Wu, Jiaping Fu, Mingzhi Zhang, Delong Liu Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in secondline setting—its impact on clinical practice Gaurav Goel, Weijing Sun Submit a manuscript Submission Guidelines Editorial Board Impact Factor: 4.81 Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network Read More Sign up to article alerts ISSN: 1756-8722 Advertisement Contact us Jobs Manage manuscripts Sign up for article alerts Manage article alerts Leave feedback Press center Read more on our blogs Policies Licensing Terms and conditions Privacy statement Accessibility Cookies Follow BioMed Central Twitter Facebook Google Plus YouTube LinkedIn Reddit Weibo © 2016 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media. By continuing to use this website, you agree to our Terms and Conditions, Privacy statement and Cookies policy.